Trade Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is an American biopharmaceutical company. The company is located in Irvine, California. Fusilev (Levoleucovorin) injection is a drug approved by the United States Food and Drug Administration in 2008 for the United States. The drug was on the market in a number of European countries. Folotyn (pralatrexate) is an anti-tax drug marketed for Lancaster or thermal peripheral T-lymphocytes. Khapzory (levoleucovorin) (Disodium Levoleucovorvorin), for injection, an analog folic acid for three indicators: decreased toxicity associated with excessive excessive folic acid or elimination of weakened methotrexate. Zevalin (ibritumomab) is referred to for the treatment of patients with relapse or refractive, low grade or follicle B-cell non-Hodgkin's lymphoma (NHL), including patients with nhl-refractive grill. It is a CD-20 radio antibody. Marqibo (Vincristine fat sulfate injection) is a sphingomyelin/cholesterol liposome coated formulation of the fda-approved anti-cancer drug vincristine. Markebo agrees to signal the treatment of adult patients with Philadelphia's negative chromosome acute lymphocytic leukemia (Ph-ALL) per second or greater relapse or which the disease progresses after two or more lines of anti-leukemia treatment. It was approved by the FDA in 2012.